We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Have a good weekend everybody. Hopefully good news next week.
Thanks
Morning, should get results to December 23 next week, not difficult to do, maybe waiting to release with PRD news which appears to be late! All feels a bit flat at the moment, need some positive to get share price moving and restore investor confidence and the shenanigans of early on in the year.
Https://x.com/prismclinactual/status/1783547472410751078?s=46
Seriously though, he ought to be ashamed of himself. He is the CEO of a company, whose products and technology are used to treat seriously ill people.
Surely, the focus should be on development to ensure that everything moves ahead as quickly as possible? Instead, side hustles are set up to enable a small number of people to make money. The World is a sadder place for having people like them in it.
I hope we get a better response to our results compared to Destiny. We seem to have been following a similar trajectory. Hopefully that changes upon good news.
Thanks
Indeed, and he wants the sp to languish for a while so that the placing looks justified. Won’t be down forever and at least the biggest hurdle of sp growth for many years has gone - the CLs
He his a genius, he knows how to shaft pi’s and make good money along with his bent mate Vassey
It’s the only saving grace cos he will want to make money from were we are
See the twitter account has run out of new things to tweet and now started tweeting old stuff. Great pr Trevor you’re an absolute genius!
Max
Day One received rare paediatric drug designation in June 2021, when they were enrolling for phase 2. That could mean we are at least 3 years behind them. However, hopefully the EAP would shorten that. They still appear to need to complete phase 3. An updated timeline from IB would really help investors understand where we currently stand in my opinion. Hopefully not much longer before we get the annual results. Thanks for finding the information. Here is a link to their RPD result:
https://ir.dayonebio.com/news-releases/news-release-details/day-one-receives-fda-rare-pediatric-disease-designation-day101
Thanks once again
Excellent find.
Thanks for highlighting. Very good news for patients. Interesting that the clinical trial was open label. If MCW run a similar trial for Glioblastoma, it would make recruitment potentially easier as all participants would be on drug.
Max
Most interesting I think it was from a phase 2 trial. That would be great if we could do that and fits in with the 2026 deadline.
Watch this space
Thanks
With the approval, Day One received a rare pediatric disease priority review voucher from the FDA
The one trade is a nonsense. I have seen stocks with 20 x 1 trades in a day and numerous other single digit trades.
The small trades or a dump of trades at the same time are usually liquidity trades by the MM or broker to move the SP or to hold it up.
There is some reference to them here in the LSE handbook.
‘Definition: market making incentive schemes that the Exchange is mandated to offer under Article 48(2)(b) of MiFID and Article 1 of Commission Delegated Regulation (EU) 2017/578
Page 58 covers it and also ALGO trades.
https://docs.londonstockexchange.com/sites/default/files/documents/rules-lse.pdf
MiFID2 MM agmt tab...
https://docs.londonstockexchange.com/sites/default/files/documents/20200401%20MIT%20&%20TE%20Parameters%20version%207.2.xls
Usual caveats
Trek
Kane - even if my life depended on it I couldn't come up with a reason we have so many pocket money trades each day ie under £10.........just don't understand why?
Well coincidence or not, within 80 mins of the 1 trade we finally have the share price lifting (albeit slightly) for the 1st time in ages. Might sell 1 share myself tomorrow and see if it goes up again....lol.
Just noticed if you click the information button next to the amount paid in the trade list it say ordinary trade executed as an si
So I googled what that is and from what I found it’s to do with the otc ?
Some say the 1 code (1 share trade) means RNS logged
The mythical 1 trade ,
This company needs a partner. Someone to steer it towards growth and presumably to work out what to do with a Phase 2 trial. Also someone who is not as mercurial as the current BOD who are doing all of our heads in.
Kane
I totally get people’s frustrations and I have only been invested for a few years. But my reading of the GaM trial is we seem to be being led by the FDA who seem desperate for it to work. All of that is outside the Board’s control. That is KS and MS doing what they are currently doing. I think somebody said after the latest shenanigans that they had spoke to Mike and he said he just gets on with the IB business. That is what we want him and the team to do. Somewhere at all the conferences somebody will eventually say we want that drug and or the image technology. At that point then it will be up to the board to get the best price available. We all know the share bears no correlation to the value of the company. We now have more universities using IB technology for their trials. Again this can only spread the word to other hospitals etc. The only way the board can make serious money is at some point to sell the whole company or IB. We all hoped it would be the PRD and subsequent voucher acting as the catalyst but that hasn’t occurred yet. But we do know that has a deadline of 2026.
Frustrating, annoying etc but IB keep moving forward.
Hopefully we get some indication of the short/medium range future either this week or next.
Thanks
Unfortunately tyke many others don’t share your optimism as we’ve been here nearly 6 years being strung along with the same old bullcrap. There is always an excuse. Stonechecker , IB stroke, LSN. Now the underperforming sales results will probably blame the non existent code thingy. When in reality the bod signed off last years results with lies in about a step change in sales and no phase 2 without substantial funding from big pharma. Feeding us lies about how they’re working tirelessly to pinpoint the anomaly between their hard work and the undervalued share price.
I’m happy to admit I was foolish enough to buy into their lies and am sitting on a 70 odd percent loss at the moment. With nothing but hope that these crooks will soon enough want to fill their pockets again and capitalise on the almost free shares they acquired at the beginning of the year. The problem is many are in the same situation as me and when even a whiff of breaking even presents it’s self many with grab it and run never to go anywhere near anything these crooks are involved in.
The fact they haven’t bothered to try and justify them robbing shareholders shows they couldn’t care less about us. It wouldn’t surprise me if he doesn’t post any results and we get suspended as this company is not being run for all shareholders just a select few.
BB
Thinking about this scenario
If it does keep happening which others have suggested as well then maybe we should all be doing the same so as to increase share holding for the same valuation.
I personally will not be doing that because I believe we will get a transformational RNS out of the blue and I don’t want to miss out on that chance. We all have to do what we think is the best for ourselves whilst IB does what is best for the patients.
In IB (and the science) I trust.
Thanks
OR
-- Great RNS - new money flows in
-- SP rises
-- BIG sells (what's going on?)
-- Bad RNS - fundraise etc
-- BoD buys up cheap stock after selling higher ...
Happens every year - twice on a Leap Year!
-- BB --